Many clinical procedures would benefit from direct and intuitive real-time visualization of anatomy, surgical plans, or other information crucial to the procedure. Three-dimensional augmented reality (3D-AR) is an emerging technology that has the potential to assist physicians with spatial reasoning during clinical interventions. The most intriguing applications of 3D-AR involve visualizations of anatomy or surgical plans that appear directly on the patient. However, commercially available 3D-AR devices have spatial localization errors that are too large for many clinical procedures. For this reason, a variety of approaches for improving 3D-AR registration accuracy have been explored. The focus of this review is on the methods, accuracy, and clinical applications of registering 3D-AR devices with the clinical environment. The works cited represent a variety of approaches for registering holograms to patients, including manual registration, computer vision-based registration, and registrations that incorporate external tracking systems. Evaluations of user accuracy when performing clinically relevant tasks suggest that accuracies of approximately 2 mm are feasible. 3D-AR device limitations due to the vergence-accommodation conflict or other factors attributable to the headset hardware add on the order of 1.5 mm of error compared to conventional guidance. Continued improvements to 3D-AR hardware will decrease these sources of error.
Despite the success of cardiac resynchronization therapy (CRT) for treating heart failure (HF), the rate of nonresponders remains 30%. Improvements to CRT require understanding of reverse remodeling and the relationship between electrical and mechanical measures of synchrony. The objective was to utilize electrocardiographic imaging (ECGI, a method for noninvasive cardiac electrophysiology mapping) and speckle tracking echocardiography (STE) to study the physiology of HF and reverse remodeling induced by CRT. We imaged 30 patients (63% male, mean age 63.7 years) longitudinally using ECGI and STE. We quantified CRT-induced remodeling of electromechanical parameters and evaluated a novel index, the electromechanical delay (EMD, the delay from activation to peak contraction). We also measured dyssynchrony using ECGI and STE and compared their effectiveness for predicting response to CRT. EMD values were elevated in HF patients compared to controls. However, the EMD values were dependent on the activation sequence (CRT-paced vs. un-paced), indicating that the EMD is not intrinsic to the local tissue, but is influenced by factors such as opposing wall contractions. After 6 months of CRT, patients had increased contraction in native rhythm compared to baseline pre-CRT (baseline: −8.55%, 6 months: −10.14%, p = 0.008). They also had prolonged repolarization at the location of the LV pacing lead. The pre-CRT delay between mean lateral LV and RV electrical activation time was the best predictor of beneficial reduction in LV end systolic volume by CRT (Spearman’s Rho: −0.722, p < 0.001); it outperformed mechanical indices and 12-lead ECG criteria. HF patients have abnormal EMD. The EMD depends upon the activation sequence and is not predictive of response to CRT. ECGI-measured LV activation delay is an effective index for CRT patient selection. CRT causes persistent improvements in contractile function.
Background: Sleeve gastrectomy is an effective bariatric procedure, however may lead to persistent symptoms without obvious mechanical cause. The normal gastric pacemaker region, which lies on the greater curvature of the corpus, is resected in sleeve gastrectomy, however, the electrophysiological consequences are not adequately defined. This study assessed these impacts and associations with symptoms and quality of life (QoL), using non-invasive gastric mapping. Methods: Patients with previous sleeve gastrectomy underwent body surface gastric mapping (Gastric Alimetry, New Zealand), comprising 30-minute fasting baseline and 4-hr post-prandial recordings. Analysis encompassed Principal Gastric Frequency (PGF), BMI-adjusted amplitude, Gastric Alimetry Rhythm Index (GA-RI), with comparison to reference intervals and matched controls. Symptoms were evaluated using a validated App and questionnaires. Results: 38 patients (median 36 months post-surgery; range 6-119 months) and 38 controls were recruited. 35/38 patients had at least one abnormal parameter, typically reduced frequencies (2.3±0.34 vs controls 3.08±0.21; p<0.001) and amplitudes (14.8±6.9 vs 31.5±17.8; p<0.001). Patients exhibited higher symptoms and lower QoL (PAGI-SYM 20 vs controls 7, p<0.001; PAGI-QOL 27 vs 136, p<0.001). Gastric amplitude and GA-RI correlated positively with bloating (r=0.71, p<0.001 and r=0.60, p=0.02) while amplitude correlated negatively with heartburn (r=-0.46, p=0.03). Lower gastric amplitudes also correlated with greater weight loss (r=-0.45; p=0.014). Conclusion: Sleeve gastrectomy modifies gastric electrophysiology due to pacemaker resection, with variable remodelling. Substantial reductions in gastric frequency and amplitude occur routinely after surgery, and specific relationships between post-sleeve gastric amplitude, symptoms of heartburn and bloating, and weight loss are identified.